Skip to main content

In-Depth Interpretation of Critical Genomic Information Related to the Biosynthesis of Key Specialized (Secondary) Metabolism in Medicinal Plants

Cover image for Research Topic "In-Depth Interpretation of Critical Genomic Information Related to the Biosynthesis of Key Specialized (Secondary) Metabolism in Medicinal Plants"
87kviews
Editorial01 September 2025
Editorial: In-depth interpretation of critical genomic information related to the biosynthesis of key specialized (secondary) metabolism in medicinal plants

Since the first plant genome was decoded just over two decades ago, research on specialized 2 metabolites has evolved from labor-intensive phytochemistry into a data-rich, multi-omics 3 enterprise. The 13 articles in this Research Topic illustrate both the impressive advances and the 4 persistent challenges in applying genomics, transcriptomics, metabolomics, and synthetic biology 5 to medicinal plants. Collectively, they investigate 11 species spanning several major metabolite 6 classes, employing strategies from telomere-to-telomere (T2T) genome assemblies to optimized 7 tissue-culture platforms. Above all, these studies demonstrate that modern natural-product science 8 is inherently integrative: pathway genes cannot be fully understood without their regulatory 9 networks, and metabolite accumulation must be interpreted in its ecological and developmental 10 contexts. 11

The first cluster of papers demonstrates how chromosome-level (including T2T) genomes unlock 13 complete mechanistic views of specialized metabolic pathways. The T2T assembly of Hedyotis 14 diffusa revealed a recent whole-genome duplication that expanded key enzyme families. Through 15 transcriptome analysis, one loganic-acid O-methyltransferase and two cytochrome P450 genes 16 were identified as late-stage iridoid tailoring enzymes, closing a critical gap in the biosynthetic 17 map (Chen et al., 2025). Mapping jasmonate-elicited RNA-seq and small RNAs to the Taxus 18 chinensis chromosome-level genome identified 990 transcription factors, 460 miRNAs and 160 19 phasiRNAs linked to paclitaxel biosynthesis. Enzyme genes were most highly expressed in cones 20 and roots, methyl jasmonate failed to induce GGPPS or CoA-ligase, and the resulting 21 miRNA-phasiRNA network buffers paclitaxel output while suggesting precise engineering targets 22 (Sun et al., 2025). In Quercus variabilis, a chromosome-level genome enabled the identification of 23 22 TCP transcription factors and revealed that TCP3 is tightly co-expressed with the 24 hydrolysable-tannin glycosyltransferase UGT84A13 in the cupule. Dual-luciferase assays 25 confirmed that TCP3 binds and activates the UGT84A13 promoter, demonstrating how 26 lineage-specific expansion of TCPs governs tissue-specific tannin accumulation (Wang et al., 27 2024a). Combined metabolomic and transcriptomic profiling of Pogostemon cablin tissues 28 showed that pogostone accumulates primarily in the roots. Mapping RNA-seq reads to the 29 reference genome, together with expression-metabolite correlation and HXXXD motif screening, 30 highlighted BAHD-DCR acyltransferases as candidate terminal enzymes for pathway engineering 31 (Wang et al., 2025a). Twenty-one 2,3-oxidosqualene cyclase (OSC) genes were identified from the 32 Panax japonicus genome, and several were found to be root-enriched and localized to the nucleus, 33 suggesting specialized roles in tissue-specific triterpenoid biosynthesis (Yang et al., 2025). Finally, 34 analysis of the Musella lasiocarpa genome identified 158 WRKY transcription factors distributed across nine chromosomes. Integrating organ-specific RNA-seq and qRT-PCR data, MlWRKY15, 36 MlWRKY111, and MlWRKY122 were co-expressed with two O-methyltransferase genes, 37 implicating these WRKYs in organ-specific regulation of phenylphenalenone biosynthesis (Huang 38 et al., 2025). Together, these studies combine high-quality genomes and integrative multi-omics to 39 dissect medicinal plant specialized metabolic pathways with unprecedented resolution, thereby 40 closing critical mechanistic gaps. 41The second group of studies showcases what can be achieved when reference genomes are 42 absent. Through integrated transcriptomic and metabolomic profiling, Wu et al. ( 2024) identified 43 seven key enzyme genes and thirteen co-expressed transcription factors central to Huperzine A 44 biosynthesis in Huperzia serrata. They further showed that phenylpropanoid and flavonoid 45 pathways were up-regulated in cultured thalli, a shift that correlated with heightened antioxidant strategies. In Taxus, the small-RNA network suggests deploying miRNA sponges or CRISPR 71 knock-outs to derepress taxoid P450s (Sun et al., 2025). Overexpressing TCP3 in Quercus could 72 enhance cupule tannin levels (Wang et al., 2024a), while tuning specific WRKY factors in Musella 73 could increase phenylphenalenone production (Huang et al., 2025). In Pogostemon, several 74 BAHD acyltransferases emerge as prime targets for enhancing pogostone (Wang et al., 2025a), 75 and in Peucedanum, upregulating the C2′H hydroxylase could elevate coumarin content (Liu et al., 76 2025). These actionable targets thus provide a roadmap for future integration with efficient 77 tissue-culture and cell-factory technologies, laying the groundwork for predictable, high-yield 78 production pipelines. 79The two review articles place these empirical advances in a broader methodological and 80 translational context. One integrates genomics, transcriptomics, proteomics and metabolomics to 81 reveal how multi-omics dissects biosynthetic gene clusters, pathway reconstruction and 82 stress-response mechanisms in medicinal plants. It also profiles bioinformatics platforms, 83 highlights single-cell and spatial transcriptomics alongside CRISPR/Cas editing, and identifies 84 challenges in data integration, standardization and dynamic pathway mapping for scalable 85 metabolite production (Wang et al., 2024b). The second review synthesizes current knowledge on 86 benzylisoquinoline alkaloid (BIA) biosynthesis by cataloguing key enzymatic steps from 87 norcoclaurine synthase to P450 monooxygenases and integrating multi-omics findings to close 88 pathway gaps. It evaluates synthetic biology strategies such as modular reconstruction in 89 microbial and plant hosts and dynamic flux control for scalable BIA production (Zhao et al., 90 2025). 91

This collection highlights two complementary paradigms for dissecting medicinal plant 93 metabolism. Genome-enabled studies exploit chromosome-level and T2T assemblies to uncover 94 duplications, gene family expansions and regulatory networks, identifying enzymes and 95 transcription factors that drive tissue-and stress-specific metabolite accumulation. Parallel efforts 96 using de novo transcriptomes, metabolite profiling and genetic markers chart biosynthetic modules 97 and post-transcriptional controls even in species lacking reference assemblies. Together, they 98 deliver a coherent set of strategies for identifying bottlenecks and engineering targets across 99 diverse metabolite classes. 100Looking forward, realizing the full complexity of plant specialized metabolism will require 101 integrating single-cell methods to resolve cell-type pathways, spatial-omics to trace metabolite 102 flux in situ and artificial intelligence-powered models to predict enzyme function and network 103 dynamics. Coupling these innovations with high-quality genomes and biochemical validation will 104 transform pathway elucidation from retrospective description to forward-looking design. Such

1,768 views

1 citations

ORIGINAL RESEARCH
19 June 2025
Metabolomic adaptations and genetic polymorphism in ecopopulations of Rhodiola linearifolia Boriss
Malika Yerbay, 10 more and Nina V. Terletskaya

2,358 views

5 citations

ORIGINAL RESEARCH
19 June 2025
The Hedyotis diffusa chromosome-level genome and multi-omics analysis provide new insights into the iridoids biosynthetic pathway
Pengyu Chen, 12 more and Lin-tao Han

3,850 views

2 citations

ORIGINAL RESEARCH
8 May 2025
Establishment of regeneration system of Peucedanum praeruptorum and molecular association analysis of coumarin secondary metabolism
Liu Tianliang, 4 more and Huang Luqi

2,125 views

2 citations

ORIGINAL RESEARCH
2 April 2025
Exploring the Metabolic and Transcriptomic Profiles of Tetrastigma hemsleyanum for Tissue-Specific Compound Accumulation
Lingxia Peng, 3 more and Xiaodan Zhang

3,047 views

4 citations

ORIGINAL RESEARCH
12 March 2025
Comprehensive characterization of the WRKY gene family and their potential roles in regulation phenylphenalenone biosynthesis in Musella lasiocarpa
Long Huang, 5 more and Wanli Zhao

2,165 views

2 citations

Benzylisoquinoline alkaloids (BIAs) are a prominent class of plant metabolites with significant pharmaceutical and industrial significance that have garnered substantial attention from researchers worldwide. BIAs exhibit several pharmacological activities and have been used extensively. Examples include analgesics such as morphine, tetrahydropalmatine, antimicrobials such as berberine, and antineoplastic agents including cepharanthine. Most BIAs are derived and isolated from medicinal plants; however, these plants are predominantly wild resources that are scarce. Their high environmental impact, slow growth rate, scarcity of resources, and expensive direct extraction costs pose a significant challenge. Certain BIAs are present in trace amounts in medicinal plants; moreover, they have complex chemical structures and unstable properties. Designing chemical synthesis routes and processes is challenging. Thus, a major obstacle in developing and utilizing these natural products in the pharmaceutical industry lies in their low abundance in nature. Consequently, the limited supply of these molecules fails to meet high research and market demands. In recent years, biosynthesis approaches have emerged as a novel and efficient method to obtain BIAs. In this review, recent progress in the field of enzymes related to the elucidation of biosynthetic pathways and the biosynthesis of BIAs are discussed, and future perspectives for designing viable strategies for their targeted manipulation are presented.

11,471 views

27 citations

ORIGINAL RESEARCH
17 February 2025
Integrated metabolomic and transcriptomic analysis of Pogostemon cablin shed new light on the complete biosynthesis pathway of pogostone
Sen Wang, 7 more and Aixia Zhang

3,300 views

2 citations

Medicinal plants are important sources of bioactive specialized metabolites with significant therapeutic potential. Advances in multi-omics have accelerated the understanding of specialized metabolite biosynthesis and regulation. Genomics, transcriptomics, proteomics, and metabolomics have each contributed new insights into biosynthetic gene clusters (BGCs), metabolic pathways, and stress responses. However, single-omics approaches often fail to fully address these complex processes. Integrated multi-omics provides a holistic perspective on key regulatory networks. High-throughput sequencing and emerging technologies like single-cell and spatial omics have deepened our understanding of cell-specific and spatially resolved biosynthetic dynamics. Despite these advancements, challenges remain in managing large datasets, standardizing protocols, accounting for the dynamic nature of specialized metabolism, and effectively applying synthetic biology for sustainable specialized metabolite production. This review highlights recent progress in omics-based research on medicinal plants, discusses available bioinformatics tools, and explores future research trends aimed at leveraging integrated multi-omics to improve the medicinal quality and sustainable utilization of plant resources.

25,235 views

83 citations

ORIGINAL RESEARCH
6 August 2024
Genome-wide identification of TCP transcription factors and their potential roles in hydrolyzable tannin production in Quercus variabilis cupule
Yaochen Wang, 5 more and Qinsong Yang

2,528 views

9 citations

ORIGINAL RESEARCH
8 May 2024
Regulatory microRNAs and phasiRNAs of paclitaxel biosynthesis in Taxus chinensis
Ming-Sheng Sun, 5 more and Liang-Jiao Xue

4,366 views

13 citations